Pre-order Enquiry
Request Free Sample
Global Drug Modeling Softwares Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
SKU ID : QYR-18704875 | Publishing Date : 07-Jul-2021 | No. of pages : 111
Detailed TOC of Global Drug Modeling Softwares Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
1 Market Overview of Drug Modeling Softwares1.1 Drug Modeling Softwares Market Overview
1.1.1 Drug Modeling Softwares Product Scope
1.1.2 Drug Modeling Softwares Market Status and Outlook
1.2 Global Drug Modeling Softwares Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Drug Modeling Softwares Market Size by Region (2016-2027)
1.4 Global Drug Modeling Softwares Historic Market Size by Region (2016-2021)
1.5 Global Drug Modeling Softwares Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Drug Modeling Softwares Market Size (2016-2027)
1.6.1 North America Drug Modeling Softwares Market Size (2016-2027)
1.6.2 Europe Drug Modeling Softwares Market Size (2016-2027)
1.6.3 Asia-Pacific Drug Modeling Softwares Market Size (2016-2027)
1.6.4 Latin America Drug Modeling Softwares Market Size (2016-2027)
1.6.5 Middle East & Africa Drug Modeling Softwares Market Size (2016-2027)
2 Drug Modeling Softwares Market Overview by Type
2.1 Global Drug Modeling Softwares Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Drug Modeling Softwares Historic Market Size by Type (2016-2021)
2.3 Global Drug Modeling Softwares Forecasted Market Size by Type (2022-2027)
2.4 Database
2.5 Software
2.6 Others
3 Drug Modeling Softwares Market Overview by Application
3.1 Global Drug Modeling Softwares Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Drug Modeling Softwares Historic Market Size by Application (2016-2021)
3.3 Global Drug Modeling Softwares Forecasted Market Size by Application (2022-2027)
3.4 Drug Discovery and Development
3.5 Computational Physiological Medicine
3.6 Disease Modelling
3.7 Medical Imaging
3.8 Predictive Analysis of Drug Targets
3.9 Simulation Software
3.10 Cellular Simulation
3.11 Others
4 Drug Modeling Softwares Competition Analysis by Players
4.1 Global Drug Modeling Softwares Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug Modeling Softwares as of 2020)
4.3 Date of Key Players Enter into Drug Modeling Softwares Market
4.4 Global Top Players Drug Modeling Softwares Headquarters and Area Served
4.5 Key Players Drug Modeling Softwares Product Solution and Service
4.6 Competitive Status
4.6.1 Drug Modeling Softwares Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 JSR Corporation(Crown Bioscience)
5.1.1 JSR Corporation(Crown Bioscience) Profile
5.1.2 JSR Corporation(Crown Bioscience) Main Business
5.1.3 JSR Corporation(Crown Bioscience) Drug Modeling Softwares Products, Services and Solutions
5.1.4 JSR Corporation(Crown Bioscience) Drug Modeling Softwares Revenue (US$ Million) & (2016-2021)
5.1.5 JSR Corporation(Crown Bioscience) Recent Developments
5.2 Chemical Computing Group ULC
5.2.1 Chemical Computing Group ULC Profile
5.2.2 Chemical Computing Group ULC Main Business
5.2.3 Chemical Computing Group ULC Drug Modeling Softwares Products, Services and Solutions
5.2.4 Chemical Computing Group ULC Drug Modeling Softwares Revenue (US$ Million) & (2016-2021)
5.2.5 Chemical Computing Group ULC Recent Developments
5.3 Nimbus Therapeutics
5.5.1 Nimbus Therapeutics Profile
5.3.2 Nimbus Therapeutics Main Business
5.3.3 Nimbus Therapeutics Drug Modeling Softwares Products, Services and Solutions
5.3.4 Nimbus Therapeutics Drug Modeling Softwares Revenue (US$ Million) & (2016-2021)
5.3.5 Schrodinger, Inc Recent Developments
5.4 Schrodinger, Inc
5.4.1 Schrodinger, Inc Profile
5.4.2 Schrodinger, Inc Main Business
5.4.3 Schrodinger, Inc Drug Modeling Softwares Products, Services and Solutions
5.4.4 Schrodinger, Inc Drug Modeling Softwares Revenue (US$ Million) & (2016-2021)
5.4.5 Schrodinger, Inc Recent Developments
5.5 Genedata AG
5.5.1 Genedata AG Profile
5.5.2 Genedata AG Main Business
5.5.3 Genedata AG Drug Modeling Softwares Products, Services and Solutions
5.5.4 Genedata AG Drug Modeling Softwares Revenue (US$ Million) & (2016-2021)
5.5.5 Genedata AG Recent Developments
5.6 Biognos AB
5.6.1 Biognos AB Profile
5.6.2 Biognos AB Main Business
5.6.3 Biognos AB Drug Modeling Softwares Products, Services and Solutions
5.6.4 Biognos AB Drug Modeling Softwares Revenue (US$ Million) & (2016-2021)
5.6.5 Biognos AB Recent Developments
5.7 Compugen Ltd
5.7.1 Compugen Ltd Profile
5.7.2 Compugen Ltd Main Business
5.7.3 Compugen Ltd Drug Modeling Softwares Products, Services and Solutions
5.7.4 Compugen Ltd Drug Modeling Softwares Revenue (US$ Million) & (2016-2021)
5.7.5 Compugen Ltd Recent Developments
5.8 Dassault Systemes
5.8.1 Dassault Systemes Profile
5.8.2 Dassault Systemes Main Business
5.8.3 Dassault Systemes Drug Modeling Softwares Products, Services and Solutions
5.8.4 Dassault Systemes Drug Modeling Softwares Revenue (US$ Million) & (2016-2021)
5.8.5 Dassault Systemes Recent Developments
5.9 Acellera
5.9.1 Acellera Profile
5.9.2 Acellera Main Business
5.9.3 Acellera Drug Modeling Softwares Products, Services and Solutions
5.9.4 Acellera Drug Modeling Softwares Revenue (US$ Million) & (2016-2021)
5.9.5 Acellera Recent Developments
5.10 Instem(Leadscope)
5.10.1 Instem(Leadscope) Profile
5.10.2 Instem(Leadscope) Main Business
5.10.3 Instem(Leadscope) Drug Modeling Softwares Products, Services and Solutions
5.10.4 Instem(Leadscope) Drug Modeling Softwares Revenue (US$ Million) & (2016-2021)
5.10.5 Instem(Leadscope) Recent Developments
6 North America
6.1 North America Drug Modeling Softwares Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Drug Modeling Softwares Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Drug Modeling Softwares Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Drug Modeling Softwares Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Drug Modeling Softwares Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Drug Modeling Softwares Market Dynamics
11.1 Drug Modeling Softwares Industry Trends
11.2 Drug Modeling Softwares Market Drivers
11.3 Drug Modeling Softwares Market Challenges
11.4 Drug Modeling Softwares Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Figures, Tables and Charts Available in Global Drug Modeling Softwares Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
List of TablesTable 1. Global Market Drug Modeling Softwares Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027
Table 2. Global Drug Modeling Softwares Market Size by Region (2016-2021) & (US$ Million)
Table 3. Global Drug Modeling Softwares Market Size Share by Region (2016-2021)
Table 4. Global Drug Modeling Softwares Forecasted Market Size by Region (2022-2027) & (US$ Million)
Table 5. Global Drug Modeling Softwares Forecasted Market Size Share by Region (2022-2027)
Table 6. Global Drug Modeling Softwares Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027
Table 7. Global Drug Modeling Softwares Market Size by Type (2016-2021) & (US$ Million)
Table 8. Global Drug Modeling Softwares Revenue Market Share by Type (2016-2021)
Table 9. Global Drug Modeling Softwares Forecasted Market Size by Type (2022-2027) & (US$ Million)
Table 10. Global Drug Modeling Softwares Revenue Market Share by Type (2022-2027)
Table 11. Global Drug Modeling Softwares Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027
Table 12. Global Drug Modeling Softwares Market Size by Application (2016-2021) & (US$ Million)
Table 13. Global Drug Modeling Softwares Revenue Market Share by Application (2016-2021)
Table 14. Global Drug Modeling Softwares Forecasted Market Size by Application (2022-2027) & (US$ Million)
Table 15. Global Drug Modeling Softwares Revenue Market Share by Application (2022-2027)
Table 16. Global Drug Modeling Softwares Revenue (US$ Million) by Players (2016-2021)
Table 17. Global Drug Modeling Softwares Revenue Market Share by Players (2016-2021)
Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug Modeling Softwares as of 2020)
Table 19. Date of Key Manufacturers Enter into Drug Modeling Softwares Market
Table 20. Global Drug Modeling Softwares Top Players Headquarters and Area Served
Table 21. Drug Modeling Softwares Product Solution and Service
Table 22. Global Drug Modeling Softwares Players Market Concentration Ratio (CR5 and HHI)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. JSR Corporation(Crown Bioscience) Basic Information List
Table 25. JSR Corporation(Crown Bioscience) Description and Business Overview
Table 26. JSR Corporation(Crown Bioscience) Drug Modeling Softwares Products, Services and Solutions
Table 27. Revenue (US$ Million) in Drug Modeling Softwares Business of JSR Corporation(Crown Bioscience) (2016-2021)
Table 28. JSR Corporation(Crown Bioscience) Recent Developments
Table 29. Chemical Computing Group ULC Basic Information List
Table 30. Chemical Computing Group ULC Description and Business Overview
Table 31. Chemical Computing Group ULC Drug Modeling Softwares Products, Services and Solutions
Table 32. Revenue (US$ Million) in Drug Modeling Softwares Business of Chemical Computing Group ULC (2016-2021)
Table 33. Chemical Computing Group ULC Recent Developments
Table 34. Nimbus Therapeutics Basic Information List
Table 35. Nimbus Therapeutics Description and Business Overview
Table 36. Nimbus Therapeutics Drug Modeling Softwares Products, Services and Solutions
Table 37. Revenue (US$ Million) in Drug Modeling Softwares Business of Nimbus Therapeutics (2016-2021)
Table 38. Nimbus Therapeutics Recent Developments
Table 39. Schrodinger, Inc Basic Information List
Table 40. Schrodinger, Inc Description and Business Overview
Table 41. Schrodinger, Inc Drug Modeling Softwares Products, Services and Solutions
Table 42. Revenue (US$ Million) in Drug Modeling Softwares Business of Schrodinger, Inc (2016-2021)
Table 43. Schrodinger, Inc Recent Developments
Table 44. Genedata AG Basic Information List
Table 45. Genedata AG Description and Business Overview
Table 46. Genedata AG Drug Modeling Softwares Products, Services and Solutions
Table 47. Revenue (US$ Million) in Drug Modeling Softwares Business of Genedata AG (2016-2021)
Table 48. Genedata AG Recent Developments
Table 49. Biognos AB Basic Information List
Table 50. Biognos AB Description and Business Overview
Table 51. Biognos AB Drug Modeling Softwares Products, Services and Solutions
Table 52. Revenue (US$ Million) in Drug Modeling Softwares Business of Biognos AB (2016-2021)
Table 53. Biognos AB Recent Developments
Table 54. Compugen Ltd Basic Information List
Table 55. Compugen Ltd Description and Business Overview
Table 56. Compugen Ltd Drug Modeling Softwares Products, Services and Solutions
Table 57. Revenue (US$ Million) in Drug Modeling Softwares Business of Compugen Ltd (2016-2021)
Table 58. Compugen Ltd Recent Developments
Table 59. Dassault Systemes Basic Information List
Table 60. Dassault Systemes Description and Business Overview
Table 61. Dassault Systemes Drug Modeling Softwares Products, Services and Solutions
Table 62. Revenue (US$ Million) in Drug Modeling Softwares Business of Dassault Systemes (2016-2021)
Table 63. Dassault Systemes Recent Developments
Table 64. Acellera Basic Information List
Table 65. Acellera Description and Business Overview
Table 66. Acellera Drug Modeling Softwares Products, Services and Solutions
Table 67. Revenue (US$ Million) in Drug Modeling Softwares Business of Acellera (2016-2021)
Table 68. Acellera Recent Developments
Table 69. Instem(Leadscope) Basic Information List
Table 70. Instem(Leadscope) Description and Business Overview
Table 71. Instem(Leadscope) Drug Modeling Softwares Products, Services and Solutions
Table 72. Revenue (US$ Million) in Drug Modeling Softwares Business of Instem(Leadscope) (2016-2021)
Table 73. Instem(Leadscope) Recent Developments
Table 74. North America Drug Modeling Softwares Market Size by Country (2016-2021) & (US$ Million)
Table 75. North America Drug Modeling Softwares Market Size by Country (2022-2027) & (US$ Million)
Table 76. Europe Drug Modeling Softwares Market Size by Country (2016-2021) & (US$ Million)
Table 77. Europe Drug Modeling Softwares Market Size by Country (2022-2027) & (US$ Million)
Table 78. Asia-Pacific Drug Modeling Softwares Market Size by Region (2016-2021) & (US$ Million)
Table 79. Asia-Pacific Drug Modeling Softwares Market Size by Region (2022-2027) & (US$ Million)
Table 80. Asia-Pacific Drug Modeling Softwares Market Share by Region (2016-2021)
Table 81. Asia-Pacific Drug Modeling Softwares Market Share by Region (2022-2027)
Table 82. Latin America Drug Modeling Softwares Market Size by Country (2016-2021) & (US$ Million)
Table 83. Latin America Drug Modeling Softwares Market Size by Country (2022-2027) & (US$ Million)
Table 84. Middle East & Africa Drug Modeling Softwares Market Size by Players (2016-2021) & (US$ Million)
Table 85. Middle East & Africa Drug Modeling Softwares Market Size by Country (2022-2027) & (US$ Million)
Table 86. Drug Modeling Softwares Market Trends
Table 87. Drug Modeling Softwares Market Drivers
Table 88. Drug Modeling Softwares Market Challenges
Table 89. Drug Modeling Softwares Market Restraints
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug Modeling Softwares Market Size Year-over-Year 2016-2027 & (US$ Million)
Figure 2. Global Drug Modeling Softwares Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 3. Global Drug Modeling Softwares Market Share by Regions: 2021 VS 2027
Figure 4. Global Drug Modeling Softwares Forecasted Market Size Share by Region (2022-2027)
Figure 5. North America Drug Modeling Softwares Market Size (US$ Million) Growth Rate (2016-2027)
Figure 6. Europe Drug Modeling Softwares Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 7. Asia-Pacific Drug Modeling Softwares Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 8. Latin America Drug Modeling Softwares Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 9. Middle East & Africa Drug Modeling Softwares Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 10. Global Drug Modeling Softwares Market Size Share by Type in 2021 & 2027
Figure 11. Database Market Size (US$ Million) YoY Growth (2016-2027)
Figure 12. Software Market Size (US$ Million) YoY Growth (2016-2027)
Figure 13. Others Market Size (US$ Million) YoY Growth (2016-2027)
Figure 14. Global Drug Modeling Softwares Market Size Share by Application in 2021 & 2027
Figure 15. Drug Discovery and Development Market Size (US$ Million) YoY Growth (2016-2027)
Figure 16. Computational Physiological Medicine Market Size (US$ Million) YoY Growth (2016-2027)
Figure 17. Disease Modelling Market Size (US$ Million) YoY Growth (2016-2027)
Figure 18. Medical Imaging Market Size (US$ Million) YoY Growth (2016-2027)
Figure 19. Predictive Analysis of Drug Targets Market Size (US$ Million) YoY Growth (2016-2027)
Figure 20. Simulation Software Market Size (US$ Million) YoY Growth (2016-2027)
Figure 21. Drug Modeling Softwares Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Top 5 and Top 10 Players Drug Modeling Softwares Market Share in 2020
Figure 23. North America Drug Modeling Softwares Market Share by Country (2016-2027)
Figure 24. United States Drug Modeling Softwares Market Size (2016-2027) & (US$ Million)
Figure 25. Canada Drug Modeling Softwares Market Size (2016-2027) & (US$ Million)
Figure 26. Germany Drug Modeling Softwares Market Size (2016-2027) & (US$ Million)
Figure 27. France Drug Modeling Softwares Market Size (2016-2027) & (US$ Million)
Figure 28. U.K. Drug Modeling Softwares Market Size (2016-2027) & (US$ Million)
Figure 29. Italy Drug Modeling Softwares Market Size (2016-2027) & (US$ Million)
Figure 30. Russia Drug Modeling Softwares Market Size (2016-2027) & (US$ Million)
Figure 31. Nordic Drug Modeling Softwares Market Size (2016-2027) & (US$ Million)
Figure 32. Rest of Europe Drug Modeling Softwares Market Size (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Drug Modeling Softwares Market Share by Region (2016-2027)
Figure 34. China Drug Modeling Softwares Market Size (2016-2027) & (US$ Million)
Figure 35. Japan Drug Modeling Softwares Market Size (2016-2027) & (US$ Million)
Figure 36. South Korea Drug Modeling Softwares Market Size (2016-2027) & (US$ Million)
Figure 37. Southeast Asia Drug Modeling Softwares Market Size (2016-2027) & (US$ Million)
Figure 38. India Drug Modeling Softwares Market Size (2016-2027) & (US$ Million)
Figure 39. Australia Drug Modeling Softwares Market Size (2016-2027) & (US$ Million)
Figure 40. Rest of Asia-Pacific Drug Modeling Softwares Market Size (2016-2027) & (US$ Million)
Figure 41. Latin America Drug Modeling Softwares Market Share by Country (2016-2027)
Figure 42. Mexico Drug Modeling Softwares Market Size (2016-2027) & (US$ Million)
Figure 43. Brazil Drug Modeling Softwares Market Size (2016-2027) & (US$ Million)
Figure 44. Rest of Latin America Drug Modeling Softwares Market Size (2016-2027) & (US$ Million)
Figure 45. Middle East & Africa Drug Modeling Softwares Market Share by Country (2016-2027)
Figure 46. Turkey Drug Modeling Softwares Market Size (2016-2027) & (US$ Million)
Figure 47. Saudi Arabia Drug Modeling Softwares Market Size (2016-2027) & (US$ Million)
Figure 48. UAE Drug Modeling Softwares Market Size (2016-2027) & (US$ Million)
Figure 49. Rest of Middle East & Africa Drug Modeling Softwares Market Size (2016-2027) & (US$ Million)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Keyplayers in Global Drug Modeling Softwares Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
JSR Corporation(Crown Bioscience)Chemical Computing Group ULC
Nimbus Therapeutics
Schrodinger, Inc
Genedata AG
Biognos AB
Compugen Ltd
Dassault Systemes
Acellera
Instem(Leadscope)
Request Sample
Request Discount
